Brandy Biederman
Family · Hixson, TNNPI 1497041180
Payments from drug & device makers
Across 1,440 payments — averaging $310.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$215K
- Novo Nordisk$91K
- Mannkind Corporation$59K
- Medtronic$23K
- Xeris Pharmaceuticals, Inc.$22K
- Bayer$12K
- plus $26K from 35 others
What the payments were for
- Consulting fees$3,4611%
- Speaking & faculty fees$360,89081%
- Travel & lodging$61,60514%
- Food & beverage$21,4135%
- Education$900%
- Gifts$1780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$184,512
- AFREZZA$55,318
- Saxenda$47,350
- Wegovy$40,905
- RECORLEV$19,343
- Minimed 770G System$14,434
- Kerendia$11,593
- Omnipod$9,700
- MINIMED 780G$7,425
- Reltone 200 Mg$7,203
- Reltone 400 Mg$7,203
- GLYCATE$7,203
- MINIMED 770G$1,096
- GVOKE HYPOPEN$860
- iLet Bionic Pancreas$361
- iLet Insulin Infusion Kit Inset$120
- iLet Insulin Infusion Kit Contact Detach$120
- TWIIST$111
How this compares
$447,638 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 662 | $1,000,818 |
| OzempicSemaglutide | 161 | $218,045 |
| AfrezzaInsulin Regular, Human | 95 | $199,617 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 71 | $123,569 |
| JardianceEmpagliflozin | 99 | $105,522 |
| TrulicityDulaglutide | 56 | $101,026 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 108 | $96,453 |
| Tresiba Flextouch U-200Insulin Degludec | 69 | $53,635 |
| LinzessLinaclotide | 43 | $27,424 |
| Humalog Kwikpen U-200Insulin Lispro | 21 | $25,549 |
| HumatropeSomatropin | 11 | $21,152 |
| SynthroidLevothyroxine Sodium | 302 | $20,865 |
| NovologInsulin Aspart | 41 | $17,136 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 14 | $16,951 |
| KerendiaFinerenone | 14 | $16,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humatrope, Humalog, Insulin Lispro | $214,574 | $1,133,585768 claims |
| Novo NordiskOzempic, Novolog, Fiasp | $91,008 | $248,118215 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $161 | $205,345219 claims |
| Mannkind CorporationAfrezza | $58,770 | $199,61795 claims |
| AbbVieLinzess, Synthroid, Armour Thyroid | $452 | $50,473378 claims |
| BayerKerendia | $12,308 | $16,42114 claims |
| Amneal Pharmaceuticals LLCUnithroid | $339 | $56219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.
Other family in Hixson
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.